Acquisition to Enhance Technological Advancements and Expand Market Share in Digital Microsurgery

GOLETA, Calif., Sept. 12, 2025 /PRNewswire/ -- B. Braun SE, a leading medical technology company, today announced the full acquisition of True Digital Surgery (TDS), a company based in Goleta, California, specializing in digital robotic-assisted 3D surgical microscopy. This acquisition highlights B. Braun's commitment to investing in the future of digital microsurgery and to expanding its market share in this growing segment.

Before the acquisition, B. Braun held a minority stake in TDS. The decision to fully acquire TDS allows B. Braun's surgical division Aesculap to secure the valuable expertise of the TDS team, ensuring the continuous technological advancement of Aesculap AEOS®, one of B. Braun's core medical products used in neurosurgery, spinal surgery, and ENT surgery.

Dr. Jens von Lackum, member of the B. Braun executive board and responsible for the surgical division Aesculap, commented on the acquisition: "This strategic move enables us to integrate the cutting-edge technology and innovative capabilities of TDS. By combining the best of both worlds, we can continue to provide our customers with best-in-class systems in robotic assisted 3D microsurgery. We are excited about the potential this acquisition brings and the opportunities to further develop our digital surgical solutions."

The high-end microsurgery market in neuro, spine and ENT surgery is undergoing a significant transformation, shifting from traditional analog microscopes to digital exoscopes, which provide excellent visualization at extreme angles and allow surgeons to operate while looking at 3D monitors instead of through an eyepiece. This also enables surgeons to stand upright during surgery, reducing physical strain.

"This merger with such a highly respected healthcare organization as B. Braun represents an exciting new milestone for True Digital Surgery and is a natural extension of the successful partnership we've enjoyed for several years. The combination of our groundbreaking technologies with B. Braun's access to the global healthcare market represents an incomparable opportunity for both companies to further improve the lives of patients and medical professionals the world over," said Aidan Foley, former TDS CEO and Chairman of the Board.

B. Braun plans for TDS to remain as a technology hub at its Goleta location. The acquisition will allow TDS and its employees to focus on their core competencies, innovating and integrating advanced technologies.

(The purchase price for the acquisition has not been disclosed.)

About B. Braun

B. Braun is a leading medical technology company. With over 64,000 employees, B. Braun is seen as a true partner, developing smart solutions and setting new standards to drive advancements in health care. In 2024, the B. Braun Group generated 9.1 billion euros in sales.

About Aesculap

As the surgical division of the B. Braun Group, Aesculap enhances treatment in the operating room and cardiac catheterization laboratory – from vital vascular interventions and innovative joint replacements to complex neurosurgical operations. Aesculap possesses a deep understanding of every surgical, interventional and supply-related process in the operating room, catheter laboratory and central sterile services department (CSSD).

About True Digital Surgery

True Digital Surgery (TDS) specializes in digital robotic-assisted 3D surgical microscopy. With a start-up-like structure and agile working methods, TDS is dedicated to developing and integrating advanced technologies to enhance surgical precision and outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/b-braun-acquires-true-digital-surgery-302554560.html

SOURCE B. Braun Medical Inc.